![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 8, 5707-5710, February 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
§,
,
,
, and
**
From the
Department of Development & Genetics,
Evolution Biology Centre, Uppsala University, Norbyvägen 18A,
S-752 36 Uppsala, Sweden and the ¶ Laboratory of Immunopathology,
NIAID, National Institutes of Health, Bethesda, Maryland 20892
Received for publication, September 26, 2001, and in revised form, December 27, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The 5'-flank of the H19 gene harbors
a differentially methylated imprinting control region that represses
the maternally derived Igf2 and paternally derived
H19 alleles. Here we show that the H19
imprinting control region (ICR) is a potent silencer when positioned in
a promoter-proximal position. The silencing effect is not alleviated by
trichostatin A treatment, suggesting that it does not involve histone
deacetylase functions. When the H19 ICR is separated from
the promoter by more than 1.2 ± 0.3 kb, however, trichostatin A
stimulates promoter activity 10-fold. Deletion analyses revealed that
the silencing feature extended throughout the ICR segment. Finally,
chromatin immunopurification analyses revealed that the H19
ICR prevented trichostatin A-dependent reacetylation of
histones in the promoter region in a proximal but not in a distal
position. We argue that these features are likely to be side effects of
the H19 ICR, rather than explaining the mechanism of
silencing of the paternal H19 allele. We issue a cautionary
note, therefore, that the interpretation of insulator/silencer data
could be erroneous should the distance issue not be taken into consideration.
The differentially methylated 5'-flank of the H19 gene
(1) is central to our understanding of how the neighboring
Igf2 and H19 genes are repressed in a
parent of origin-dependent manner. Genetic experiments have
demonstrated its involvement in the repression of the maternal
Igf2 and paternal H19 alleles (2). The
silenced maternal Igf2 allele requires the continuous
presence of the H19 imprinting control region
(ICR)1 (3), which has been
proposed to function as a chromatin insulator by default (4-7). In
line with this supposition, the H19 ICR has no insulator
function when methylated (8).
The notion that the methylated status of the H19 ICR
involves recruitment of repressive factors that propagate an inactive chromatin toward the H19 promoter (3) is supported by the
observation that MeCP2 and MBD 2/3 are associated preferentially with
the paternal H19 ICR allele in chromatin immunopurification
assays.2 However, because the
unmethylated H19 ICR performed as an efficient silencer in
transgenic Drosophila assays, it has been claimed that the
H19 ICR contains silencing features by default (9). To
resolve this paradox, we set out to examine if the unmethylated H19 ICR can act as a silencer under certain circumstances.
Cell Culture
The JEG-3 human choriocarcinoma cell line was maintained in
modified Glutamax Eagle's medium (Life Technologies, Inc.),
supplemented with 10% fetal bovine serum, glutamate, and
penicillin/steptomycin (Life Technologies, Inc.) as described
previously (10). Trichostatin A (TSA, Wako GmbH, Neuss, Germany) was
added to the culture medium at a final concentration of 5.0 × 10 Plasmid Constructs
The construction of the pSIS vector (based upon the
PDGF-B promoter) with CAT gene has been described previously
(10).
pSISICRS (in + or pSISICR (+/ Transfections and CAT Assays
Transfections were carried out with equimolar amounts of the
plasmid DNAs (5 µg for the basal promoter constructs) and 0.5 µg of
a reference plasmid containing a Chromatin Immunopurification Assay
Transfected cells were harvested and formaldehyde-cross-linked,
as has been described (12). Following isolation of nuclei and
sonication to shear the DNA, the histone-containing DNA-protein complexes were immunopurified using antibodies to acetylated histones H3 and H4 as well as unacetylated H4 (Upstate Biotechnology Inc., Lake
Placid, NY) and protein A4 Fast Flow-Sepharose beads
(Pharmacia-Upjohn). The immunopurified DNA was PCR-amplified using
forward primers 5'-GTGACAAAGCTTGAGTACCC-3' and 5'-GCAGCTTCAGTGTGGCAG-3'
for ICR and spacer, respectively, and the common reverse primer
5'-TCAGGAGGAGAAGTTGCCAC-3'. The PCR conditions were 1 × 94 °C for 5 min, 1 × 94 °C for 30 s, 1 × 58 °C for 30 s, 1 × 72 °C for 90 s, 24 × (94 °C for 30 s, 58 °C for 30 s, 72 °C for 90 s), and 1 × 72 °C for 5 min. The PCR products were visualized
on 2% agarose gels stained with SYBRGreen (Molecular Probes, Eugene,
OR), and images were analyzed with Fuji-film Image Reader LAS-1000.
We focused on a 1.2-kb segment of the H19 ICR that
encompasses a major portion of the differentially methylated domain
(Fig. 1A) and displays strong
insulator activity (4). This fragment was inserted into CAT reporter
vectors that were equipped with either the H19 or
PDGF-B promoter. Fig. 1B shows that the basal activity of the PDGF-B promoter was reduced 5-fold when the
H19 ICR was inserted in either orientation in a
promoter-proximal position. This effect was neutralized when the
natural spacer was inserted between the H19 ICR and the
PDGF-B promoter. Similar results were obtained using the
mouse H19 promoter (data not shown). Because the repressive
effect reappeared when the spacer-H19 ICR fragment was
reversed, i.e. ICR-proximal, spacer-distal, the effect of
the spacer on the repressive properties of the ICR is
position-dependent.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
8 M, 28 h after transfection. The
cells were harvested after a 14-h exposure to TSA.
Orientation)--
The 3.35-kb
H19 ICR, including the natural "spacer," which refers to
the endogenous H19 sequence that lies between the ICR and
promoter, was inserted into the multiple cloning site of pSIS at
BamHI-XbaI using non-directional A/T cloning strategy.
)--
The 1.4-kb AvrII-XbaI
fragment of H19 ICR (4) was ligated into the
XbaI-digested pSIS vector in either orientation.
pSISICRS
1 was generated by digesting with
AccI-EcoRV and removing a 470-bp fragment from
the parent ICR natural spacer construct and religating the two ends by
blunt-end cloning. pSISICRS
2 was made by digestion with
AflIII-EcoRV and removing a 1020-bp fragment from
the parent construct and religating the two ends after a fill-in
reaction to create blunt ends. pSISICRS
3 was created by deleting 550 bp by AflIII-AccI restriction digestion followed
by blunt-end ligation. pSISICRS
4 was generated by inserting a 550-bp
fragment of AflIII-AccI from the H19
natural spacer. PSISA/PSISICRA plasmids were generated by inserting a
1.94-kb neutral fragment of the pERGR (11) with XbaI-SalI digestion followed by blunt-end
ligation into the XbaI site of the pSIS and pSISICR
plasmids. The pSISS1S2 construct (with mutated CTCF target sites) was
generated by cloning a 1.4-kb KpnI/AvrII
blunt-end fragment from pCR2.1-S1S2 (7) into BamHI, the
Klenow-filled site of pSISCAT vector. The pSISHI, pSISHII, and pSISNH
constructs were generated by PCR amplification of the different parts
of the ICR using the following primer pairs (see map of Fig.
4A): HI, 5'-AAAACCCGGGGCTATGCCTCAGTGGTCGAT-3' and 5'-AAAACCCGGGGGCTGTGTAGGGAATGAGTCA-3'; HII,
5'-AAAACCCGGGTTCATAAGGGTCATGGGGTG-3' and
5'-AAAACCCGGGGTCTCCCGCCTATAACCGAT-3'; NH,
5'AAAACCCGGGTCACTTAAGGAACCGCCAAC-3' and
5'-AAAACCCGGGATCGACCACTGAGGCATAGC-3'. The amplified fragments were (A/T)-subcloned into pCR2.1 (Invitrogen). The ICR fragments were
restricted by BamHI and XbaI and inserted
into the BamHI/XbaI sites of pSISCAT.
-galactosidase reporter gene under
the control of the SV40 promoter-enhancer (pSV
Gal), as has been
described previously (10). The amount of protein extracts taken for CAT
assay (10) was adjusted within each given experiment according to the
-galactosidase activity-assessed transfection efficiency but
averaged around 100 µg for JEG-3. Relative CAT assays were quantified
using a Fuji FLA 3000 phosphorimaging device. The results shown
represent the mean data pooled from 3-16 independent transfection experiments.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 1.
Schematic presentation of
the 5'-flank of the mouse H19 gene. A,
the imprinting control region (violet bar) with endogenous
spacer (green bar) juxtaposed to the H19 promoter
(purple bar). The ICR and spacer segment used in the studies
are indicated in the figure. B, the pSIS constructs were
based on the PDGF-B promoter (red bar) followed
by a CAT (yellow bar) reporter gene. CAT activity is
represented by bar diagrams with S.E. of 3-16 independent
transfections. The units of expression were harmonized with the other
panels to allow comparison and are related to TSA-stimulated expression
shown in Fig. 2.
Given that gene silencing functions frequently involve histone
deacetylation (13), we also examined the performance of these constructs following treatment with TSA, which is an inhibitor of
several histone deacetylases (14) and will activate the paternal H19 allele in mouse embryos (15). TSA treatment of
transfected cells enhanced the activity of the basal PDGF-B
promoter 10-fold but had little effect on the activity of the
PDGF-B promoter when this was juxtaposed to the
H19 ICR (Fig. 2A).
To determine whether these effects could be directly related to the
histone acetylation status of the PDGF-B promoter, we
employed chromatin immunopurification assays. Plasmids with the
H19 ICR either separated from the promoter by the spacer or
juxtaposed to the PDGF-B promoter were mixed in equimolar
proportions and transfected into JEG-3 cells. Following administration
of TSA during the last 14 h before cell harvest and formaldehyde
fixation, cross-linked DNA-protein complexes were immunopurified
followed by multiplex PCR analysis (see strategy in Fig.
2B). Fig. 2C shows a mixing experiment to ensure
that the promoter configurations in the two plasmids could be amplified without ratio distortions. Fig. 2C also shows that the
antibodies against the acetylated forms of histones H3 and H4 pulled
down sequences primarily representative of the plasmid with a
1.8-kb natural spacer element separating the H19 ICR from
the promoter. As a positive control we used histone H4 antibodies that
pulled down sequences from both plasmids with a slight preference for the plasmid without the spacer segment (Fig. 2C). We
conclude that the proximity of the H19 ICR directly
controlled the histone acetylation status at the promoter of the
reporter gene.
|
To further examine the distance-dependent effects, we
generated deletion mutants of the spacer that placed the H19
ICR closer to the PDGF-B promoter (Fig.
3A). Fig. 3B shows
that repression via the H19 ICR was abrogated when located
more distally from the promoter, with the critical distance mapping
somewhere between 856 and 1456 bp. To deal with an argument that this
distance dependence might be due to the deletion of an additional
cis element in the spacer region, we inserted a 1.94-kb
exonic fragment derived from the gluocorticoid receptor gene between
the PDGF-B promoter and the H19 ICR. Fig.
3B shows that the repressor function was eliminated in this
construct (pSISICRA). We conclude, therefore, that the H19
ICR represses cis regulatory elements in a
distance-dependent manner but independent of the sequence
of the intervening DNA.
|
Next we examined whether or not the CTCF target sites that organize the
insulator function of the H19 ICR (7) were responsible for
the repressive features. Fig.
4B shows that the two
fragments that harbor CTCF target sites (Fig. 4A) indeed act
as silencers in promoter-proximal positions with and without TSA.
However, the pSISNH (covering a region 5' of the CTCF target sites) and pSISS1S2 (with mutated CTCF target sites) constructs revealed that the
silencer features do not require the CTCF target sites (Fig.
4B). We conclude that minimally three different and
non-overlapping cis elements within the H19 ICR
organize a distance-dependent silencer.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major point of this report is that a distance-dependent silencing function is a side effect of the H19 ICR. If proven general for insulator and silencer elements, this feature might complicate interpretations on both position-dependent and independent silencing functions should the distance issue not be taken into consideration. The reasons underlying our conclusions are 3-fold. Firstly, despite our demonstration of the H19 ICR silencer function, the H19 gene in the 3'-flank of the H19 ICR is transcriptionally active on the maternal chromosome. Secondly, whereas the minimum distance for neutralizing the silencer function was 1.34 kb between the H19 ICR and the promoter of the reporter gene, both the mouse and human H19 ICRs are separated by 2 kb despite no similarity in the intervening sequence. Hence, the H19 ICR appears to be separated from the H19 promoter by an obligatory "spacing" region in order to avoid adverse effects on H19 expression. Thirdly, whereas the H19 ICR-induced silencing of the paternal H19 allele could be neutralized by TSA treatment during in vitro mouse embryogenesis (15), the distance-dependent H19 ICR silencer was TSA-insensitive.
What could be the cause for the distance-dependent
repressor effect by the H19 ICR? One possibility that comes
to mind is an H19 ICR-specific recruitment of a
TSA-insensitive histone deacetylase that locally changes the histone
acetylation status to form a repressive chromatin conformation. This
possibility is seemingly supported by the demonstration that CTCF,
which interacts with two different binding sites within the
H19 ICR fragment analyzed in this report, is able to recruit
histone deacetylases (16). Given that deletion and mutation analyses
reveal that the silencing features might include but clearly do not
depend on CTCF target sites, however, this scenario is less likely.
Instead, we favor the interpretation that multiple cis
elements within the H19 ICR collaborate to organize a
chromatin conformation that sterically prevents accessability of
regulatory factors to juxatposed promoter and enhancer elements. Such
cis elements, including the CTCF target sites, might jointly
organize a normally protective shield around the maternal
H19 ICR allele against de novo methylation.
| |
FOOTNOTES |
|---|
* This work was supported by the Swedish Natural Science Research Council (NFR), the Swedish Pediatric Cancer Research Foundation (BCF), The Lundberg Foundation, and the Swedish Cancer Research Foundation (CF).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Current address: Dept. of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, S-751 85 Uppsala, Sweden.
Current address: Biacore AB, Rapsgatan 7, S-754 50, Uppsala, Sweden.
** To whom correspondence and requests for materials should be addressed. Tel.: 46-184712660; Fax: 46-184712683; E-mail address: Rolf.Ohlsson@ebc.uu.se.
Published, JBC Papers in Press, January 2, 2002, DOI 10.1074/jbc.C100552200
2 C. Kanduri, A. Wolffe, and R. Ohlsson, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ICR, imprinting control region; CAT, chloramphenicol acetyltransferase; PDGF, platelet-derived growth factor; TSA, trichostatin A.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Olek, A., and Walter, J. (1997) Nat. Genet. 17, 275-276[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Thorvaldsen, J. L.,
Duran, K. L.,
and Bartolomei, M. S.
(1998)
Genes Dev.
12,
3693-3702 |
| 3. |
Kaffer, C. R.,
Srivastava, M.,
Park, K. Y.,
Ives, E.,
Hsieh, S.,
Batlle, J.,
Grinberg, A.,
Huang, S. P.,
and Pfeifer, K.
(2000)
Genes Dev.
14,
1908-1919 |
| 4. | Kanduri, C., Holmgren, C., Franklin, G., Pilartz, M., Ullerås, E., Kanduri, M., Liu, L., Ginjala, V., Mattsson, R., and Ohlsson, R. (2000) Curr. Biol. 10, 449-457[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Bell, A. C., and Felsenfeld, G. (2000) Nature 405, 482-485[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Hark, A. T., Schoenherr, C. J., Katz, D. J., Ingram, R. S., Levorse, J. M., and Tilghman, S. M. (2000) Nature 405, 486-489[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Kanduri, C., Pant, V., Loukinov, D., Pugacheva, E., Qi, C.-F., Wolffe, A., and Lobanenkov, A. (2000) Curr. Biol. 10, 853-856[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Holmgren, C., Kanduri, K., Dell, G., Ward, A., Mukhopadhya, R., Kanduri, M., Lobanenkov, V., and Ohlsson, R. (2001) Curr. Biol. 11, 1128-1130[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Lyko, F., Brenton, J. D., Surani, M. A., and Paro, R. (1997) Nat. Genet. 16, 171-173[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Franklin, G., Donovan, M., Adam, G., Holmgren, L., Specht, A., Pfeifer- Ohlsson, S., and Ohlsson, R. (1991) EMBO J. 10, 1365-1373[Medline] [Order article via Infotrieve] |
| 11. | Ullerås, E., Miller, S., Adam, G., Kanduri, C., Wilcock, A., and Franklin, G. (2001) Exp. Cell Res. 270, 188-198[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Kanduri, M., Kanduri, C., Vostrov, A., Quitschke, W., Lobanenkov, V., and Ohlsson, R. (2001) Mol. Cell. Biol., in press |
| 13. | Grunstein, M. (1997) Nature 389, 349-352[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Yoshida, M., Horinouchi, S., and Beppu, T. (1995) Bioessays 17, 423-430[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Svensson, K., Mattsson, R., James, T., Wentzel, P., Pilartz, M., MacLaughlin, J., Miller, S., Olsson, T., Eriksson, U., and Ohlsson, R. (1998) Development 125, 61-69[Abstract] |
| 16. |
Lutz, M.,
Burke, L.,
Barreto, G.,
Goeman, F.,
Greb, H.,
Arnold, R.,
Schultheiss, H.,
Brehm, A.,
Kouzarides, T.,
Lobanenkov, V.,
and Renkawitz, R.
(2000)
Nucleic Acids Res.
28,
1707-1713 |
This article has been cited by other articles:
![]() |
M. S. Anglesio, V. Evdokimova, N. Melnyk, L. Zhang, C. V. Fernandez, P. E. Grundy, S. Leach, M. A. Marra, A. R. Brooks-Wilson, J. Penninger, et al. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney Hum. Mol. Genet., September 15, 2004; 13(18): 2061 - 2074. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |